Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
115597-84-7
86099-06-1
34321-81-8
79364-17-3
660843-22-1
125008-83-5
211746-78-0 | Peg5-(ch2co2t-butyl)2 | AA019E1U | MFCD29079384
2055103-66-5 | Carboxyrhodamine 110-PEG4-alkyne | AA019E5R | MFCD30458035
2100306-47-4 | N-(Amino-peg1)-n-bis(peg2-propargyl) | AA019E9P | MFCD30723225
90784-86-4 | M-Peg6-2-methylacrylate | AA019EEG | MFCD31561109
876555-60-1 | N-(5-fluoro-2-methylphenyl)-4-methylbenzenesulfonamide | AA019EHY | MFCD05139663
119916-08-4 | 4,6-Dibromo-3-fluoro-2-methyl-benzoic acid methyl ester | AA019EKM | MFCD30295018
546101-12-6 | DIMETHYL 1,3-DIMETHYLCYCLOPENTANE-1,3-DICARBOXYLATE | AA019EO2 | MFCD28559200
1772777-01-1 | 4-bromo-N-(3-bromophenyl)-2-fluorobenzenesulfonamide | AA019ERE | MFCD27824753
1772774-30-7 | 4-bromo-N-(2-chloro-4-methylphenyl)-2-fluorobenzenesulfonamide | AA019EUN | MFCD28098727
58778-52-2 | Pyridine, 1,2,3,6-tetrahydro-4-[4-(trifluoromethyl)phenyl]-, hydrochloride | AA019EXU | MFCD20502062